Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirtobrutinib Combined With Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
NCT07744724Phase 2Not yet recruiting
- Sponsor
- Changzhou Second People's Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 2 trial of pirtobrutinib in diffuse large B-cell lymphoma (DLBCL), sponsored by Changzhou Second People's Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
pirtobrutinib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07744724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07744724.